Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients

Background Iron overload is a predictable and life-threatening complication in patients dependent on the regular transfusion of RBCs. The aims of this study were to investigate the efficacy and safety of deferiprone in a variety of pediatric hematologic and/or oncologic patients with a high iron overload.